American Journal of Transplantation · 2006 · 56 citations · 19 references
Life SciencesImmunologyNephrologyImmunizationKidney TransplantationTransplant ImmunologyImmune ToleranceImmunological ToleranceImmunosuppression In Kidney TransplantationT Cell ToleranceTolerance MechanismsTransplant ToleranceGraft Immunologic ToleranceHemagglutination AssaysHemagglutination Inhibition AssaysImmunologic Response To AllograftLong-term Graft FunctionOperational ToleranceTransplant Tolerance MechanismsVaccination In Transplant Recipients
Rare kidney allograft recipients enjoy unaltered graft function years after interruption of their immunosuppressive treatment. To assess the extent to which this state of ‘operational tolerance’ (TOL) is specific to the graft and not the result of a global immunodeficiency, we analyzed the response of such patients following influenza vaccination. Hemagglutination inhibition titers and frequency of IFNγ-secreting T cells were measured before 1 and 3 months after vaccination. The proportion of healthy volunteers (HV) responding to vaccine was significantly higher than that of immunosuppressed (IS) patients. Three ‘TOL’ patients presented a humoral response similar to that of HV, whereas the two others had a poor response, like the IS recipients. Although the small number of patients does not allow for definitive conclusions to be made, these data suggest that the status of tolerance may be heterogeneous, with some patients with a global immunodeficiency and others with an adapted response to vaccination. Rare kidney allograft recipients enjoy unaltered graft function years after interruption of their immunosuppressive treatment. To assess the extent to which this state of ‘operational tolerance’ (TOL) is specific to the graft and not the result of a global immunodeficiency, we analyzed the response of such patients following influenza vaccination. Hemagglutination inhibition titers and frequency of IFNγ-secreting T cells were measured before 1 and 3 months after vaccination. The proportion of healthy volunteers (HV) responding to vaccine was significantly higher than that of immunosuppressed (IS) patients. Three ‘TOL’ patients presented a humoral response similar to that of HV, whereas the two others had a poor response, like the IS recipients. Although the small number of patients does not allow for definitive conclusions to be made, these data suggest that the status of tolerance may be heterogeneous, with some patients with a global immunodeficiency and others with an adapted response to vaccination.
19
Clinical Operational Tolerance after Kidney Transplantation
G. Roussey‐Kesler, Magali Giral, J.F. Subra et al. · American Journal of Transplantation · 2006 · 187 citations
Medicine, Nephrology, Surgery +13